Catalyst Wire Dossier Catalyst Wire Dossier

Cytovene-IV

ganciclovir · Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cytovene-IV, covering 2013-07-23 to 2013-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant [Phase 3]

See pricing